Insights on Clinical Trials

  1. DPCR, qPCR, And RT-qPCR: Advantages And Challenges In Development 5/27/2026

    Discover how the right PCR strategy, combined with thoughtful assay design and validation, can strengthen confidence in your molecular research and clinical testing workflows.

  2. The ctDNA Clinical Trial Advantage 5/27/2026

    See how CROs are helping shape the future of ctDNA research—translating emerging data, regulatory insights, and biomarker innovation into faster, smarter oncology development.

  3. Mergers And Acquisitions: How Institutional Knowledge Protecting Value 5/27/2026

    M&A transitions can either preserve momentum or create costly setbacks. Learn how protecting institutional knowledge helps sponsors reduce risk, maintain continuity, and accelerate development.

  4. De-Risking The Neurology IND: Lessons From Early FDA Engagement 5/27/2026

    Learn how early FDA alignment can help your neurology program move forward with greater clarity, confidence, and regulatory readiness.

  5. Relieving Pressure During Preparation Of A High-Volume sNDA 5/27/2026

    Managing a complex sNDA under pressure? See how one sponsor achieved an early FDA submission through coordinated publishing, regulatory strategy, and flawless execution.

  6. Supporting Global Approval Of A First-In-Class Gene Therapy For A Rare Genetic Disorder 5/27/2026

    Global approvals for a first-in-class gene therapy don’t happen by chance. See how adaptive oversight and inspection readiness kept a complex rare disease program moving forward.

  7. Building A Competitive, Patient‑First Future For Rare Diseases In Europe 5/22/2026

    The EURORDIS Round Table shows how Europe can align regulatory reform and patient-centered design to strengthen competitiveness and improve access to rare disease innovation across Member States.

  8. Debunking Regulatory Myths In CGT Orphan Drug Development 5/22/2026

    We have debunked five common myths that cell and gene therapy developers believe about regulatory expectations for orphan drugs.

  9. Rare Disease Development: Navigating Small Populations And Complex Protocols 5/22/2026

    Learn how you can navigate the complexity of rare disease development with flexible trial design, integrated regulatory strategy, and data-driven execution built for small populations and global programs.

  10. The Compound Effect Of Specialized Knowledge 5/22/2026

    How does specialized knowledge compound over time into foresight, stronger execution, and more confident decision-making across the drug development lifecycle?